Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis.
Saved in:
| Title: | Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis. |
|---|---|
| Authors: | Berning P; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany., Maulhardt M; Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany., Boyadzhiev H; Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland.; Habichtswald Hospital, Kassel, Germany., Albici AM; University Hospital Schleswig-Holstein, Kiel, Division of Stem Cell Transplantation and Cellular Immunotherapies, Kiel University, Kiel, Germany., Janjetovic S; Department of Hematology, Oncology, and Tumor Immunology Helios Klinikum Berlin-Buch, Berlin, Germany., Ossami Saidy A; Department of Hematology, Oncology, and Tumor Immunology Helios Klinikum Berlin-Buch, Berlin, Germany., Schultze-Florey C; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Call S; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany., Stölzel F; University Hospital Schleswig-Holstein, Kiel, Division of Stem Cell Transplantation and Cellular Immunotherapies, Kiel University, Kiel, Germany., Brioli A; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Daskalakis M; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Knust J; Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany., Hasenkamp J; Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany., Wurm-Kuczera R; Department of Hematology, Oncology, and Cancer Immunology, Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Pohlmann A; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany., Stelljes M; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany., Khandanpour C; Department of Hematology and Oncology, University Hospital of Schleswig-Holstein, University of Lübeck, Lübeck, Germany., Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Boquoi A; Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Heidel FH; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.; Cellular Therapy Center (CTC), Hannover Medical School (MHH), Hannover, Germany., Reinhardt HC; Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Wulf G; Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany., Schub N; University Hospital Schleswig-Holstein, Kiel, Division of Stem Cell Transplantation and Cellular Immunotherapies, Kiel University, Kiel, Germany., von Tresckow B; Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Lenz G; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany., Pabst T; Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland., Shumilov E; Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany. evgenii.shumilov@ukmuenster.de. |
| Source: | Blood cancer journal [Blood Cancer J] 2026 Jun 02; Vol. 16 (1). Date of Electronic Publication: 2026 Jun 02. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
